Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?

Por Eyre, Toby A.
Publicado no Oncotarget (2018)

Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?

Por Eyre, Toby A.
Publicado no Oncotarget (2019)

Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma

Por Kesavan, Murali, Eyre, Toby A., Collins, Graham P.
Publicado no Curr Hematol Malig Rep (2019)

Multiple myeloma in the very elderly patient: challenges and solutions

Por Willan, John, Eyre, Toby A, Sharpley, Faye, Watson, Caroline, King, Andrew J, Ramasamy, Karthik
Publicado no Clin Interv Aging (2016)

Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter’s syndrome

Por Eyre, Toby A, Clifford, Ruth, Roberts, Corran, Boyle, Lucy, Francis, Anne, Schuh, Anna, Dutton, Susan J
Publicado no BMC Cancer (2015)

The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly dia...

Por Appleby, Niamh, Eyre, Toby A., Cabes, Maite, Jackson, Aimee, Boucher, Rebecca, Yates, Francesca, Fox, Sonia, Rawstron, Andrew, Hillmen, Peter, Schuh, Anna
Publicado no BMC Cancer (2019)

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy

Por Eyre, Toby A., Walter, Harriet S., Iyengar, Sunil, Follows, George, Cross, Matthew, Fox, Christopher P., Hodson, Andrew, Coats, Josh, Narat, Santosh, Morley, Nick, Dyer, Martin J.S., Collins, Graham P.
Publicado no Haematologica (2019)

Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study

Por Cuneo, Antonio, Follows, George, Rigolin, Gian Matteo, Piciocchi, Alfonso, Tedeschi, Alessandra, Trentin, Livio, Perez, Angeles Medina, Coscia, Marta, Laurenti, Luca, Musuraca, Gerardo, Farina, Lucia, Delgado, Alfredo Rivas, Orlandi, Ester Maria, Galieni, Piero, Mauro, Francesca Romana, Visco, Carlo, Amendola, Angela, Billio, Atto, Marasca, Roberto, Chiarenza, Annalisa, Meneghini, Vittorio, Ilariucci, Fiorella, Marchetti, Monia, Molica, Stefano, Re, Francesca, Gaidano, Gianluca, Gonzalez, Marcos, Forconi, Francesco, Ciolli, Stefania, Cortelezzi, Agostino, Montillo, Marco, Smolej, Lukas, Schuh, Anna, Eyre, Toby A., Kennedy, Ben, Bowles, Kris M., Vignetti, Marco, de la Serna, Javier, Moreno, Carol, Foà, Robin, Ghia, Paolo
Publicado no Haematologica (2018)

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

Por Mato, Anthony R., Roeker, Lindsey E., Eyre, Toby A., Nabhan, Chadi, Lamanna, Nicole, Hill, Brian T., Brander, Danielle M., Barr, Paul M., Lansigan, Frederick, Cheson, Bruce D., Singavi, Arun K., Yazdy, Maryam Sarraf, Shah, Nirav N., Allan, John N., Bhavsar, Erica B., Rhodes, Joanna, Kennard, Kaitlin, Schuster, Stephen J., Williams, AnnaLynn M., Skarbnik, Alan P., Goy, Andre H., Goodfriend, Julie M., Dorsey, Colleen, Coombs, Catherine C., Tuncer, Hande, Ujjani, Chaitra S., Jacobs, Ryan, Winter, Allison M., Pagel, John M., Bailey, Neil, Schuh, Anna, Shadman, Mazyar, Sitlinger, Andrea, Weissbrot, Hanna, Muralikrishnan, Sivraj, Zelenetz, Andrew, Kirkwood, Amy A., Fox, Christopher P.
Publicado no Blood Adv (2019)